Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies
Kimberly G. Wagoner, Olivia E. Horton, Cynthia K. Suerken, E. Alfonso Romero-Sandoval et al. • Preventive Medicine Reports
(2026)
Objectives: We assessed point-of-sale advertising for CBD in three states with different cannabis laws (i.e., medical/recreational use; medical only; CBD/low THC) to determine if CBD is marketed in ways that are prohibited by the U.S. Food ...
DOAJ
Open Access (DOAJ)
DOI:
10.1016/j.pmedr.2026.103472